[1]
Huang, W.K.; Juang, Y.Y.; Chung, C.C.; Chang, S.H.; Chang, J.W.C.; Lin, Y.C.; Wang, H.M.; Chang, H.K.; Chen, J.S.; Tsai, C.S.; Yu, K.H. Timing and risk of mood disorders requiring psychotropics in long-term survivors of adult cancers: A nationwide cohort study. J. Affect. Disorders , 2018, 236, 80-87.
[2]
Rodzinski, A.; Guduru, R.; Liang, P.; Hadjikhani, A.; Stewart, T.; Stimphil, E.; Runowicz, C.; Cote, R.; Altman, N.; Datar, R.; Khizroev, S. Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles. Sci. Reports, 2016, 6, 20867.
[3]
Bahrami, B.; Hojjat-Farsangi, M.; Mohammadi, H.; Anvari, E.; Ghalamfarsa, G.; Yousefi, M.; Jadidi-Niaragh, F. Nanoparticles and targeted drug delivery in cancer therapy. Immunol. Lett., 2017, 190, 64-83.
[4]
Shi, G.N.; Zhang, C.N.; Xu, R.; Niu, J.F.; Song, H.J.; Zhang, X.Y.; Wang, W.W.; Wang, Y.M.; Li, C.; Wei, X.Q.; Kong, D.L. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine. Biomaterials, 2017, 113, 191-202.
[5]
Turner, N.; Ware, O.; Bosenberg, M. Genetics of metastasis: melanoma and other cancers. Clin. Experiment. Metastasis, 2018, 35, 379-391.
[6]
Marta, T.; Luca, S.; Serena, M.; Luisa, F.; Fabio, C. What is the role of nanotechnology in diagnosis and treatment of metastatic breast cancer? Promising scenarios for the near future. J. Nanomaterials, 2016, 20165436458
[7]
Doktorovova, S.; Souto, E.B.; Silva, A.M. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): In vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines. Pharmaceut. Develop Technol., , 2018, 23(1), 96-105.
[8]
Bianchi, G.; Ravera, S.; Traverso, C.; Amaro, A.; Piaggio, F.; Emionite, L.; Bachetti, T.; Pfeffer, U.; Raffaghello, L. Curcumin induces a fatal energetic impairment in tumor cells in vitro and in vivo by inhibiting ATP-synthase activity. Carcinogenesis, 2018, 39(9), 1141-1150.
[9]
Xie, J.; Yong, Y.; Dong, X.; Du, J.; Guo, Z.; Gong, L.; Zhu, S.; Tian, G.; Yu, S.; Gu, Z.; Zhao, Y. Therapeutic nanoparticles based on curcumin and bamboo charcoal nanoparticles for chemo-photothermal synergistic treatment of cancer and radioprotection of normal cells. ACS Applied Mater. Interfaces, 2017, 9(16), 14281-14291.
[10]
Sahin, K.; Orhan, C.; Tuzcu, M.; Sahin, N.; Tastan, H.; Özercan, İ.H.; Güler, O.; Kahraman, N.; Kucuk, O.; Ozpolat, B. Chemopreventive and antitumor efficacy of curcumin in a spontaneously developing hen ovarian cancer model. Cancer Prevent Res. , 2018, 11(1), 59-67.
[11]
Fehl, D.J.; Ahmed, M. Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers. Virus Res., 2017, 228, 14-23.
[12]
Bimonte, S.; Barbieri, A.; Palma, G.; Rea, D.; Luciano, A.; D’Aiuto, M.; Arra, C.; Izzo, F. Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer. BioMed Res. Int., 2015, 2015878134
[13]
Larasati, Y.A.; Yoneda-Kato, N.; Nakamae, I.; Yokoyama, T.; Meiyanto, E.; Kato, J.Y. Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth. Sci. Reports, 2018, 8(1), 2039.
[14]
Li, M.; Yue, G.G.L.; Tsui, S.K.W.; Fung, K.P.; Bik-San Lau, C. Turmeric extract, with absorbable curcumin, has potent anti-metastatic effect in vitro and in vivo. Phytomedicine, 2018, 46, 131-141.
[15]
Jose, A.; Labala, S.; Ninave, K.M.; Gade, S.K.; Venuganti, V.V.K. Effective skin cancer treatment by topical co-delivery of curcumin and STAT3 siRNA using cationic liposomes. AAPS PharmSciTech, 2018, 19(1), 166-175.
[16]
Pan, Z.; Zhuang, J.; Ji, C.; Cai, Z.; Liao, W.; Huang, Z. Curcumin inhibits hepatocellular carcinoma growth by targeting VEGF expression. Oncol. Lett., 2018, 15(4), 4821-4826.
[17]
Green, C.E.; Mitchell, S.A. The effects of blanching, harvest time and location (with a minor look at postharvest blighting) on oleoresin yields, percent curcuminoids and levels of antioxidant activity of turmeric (Curcuma longa) rhizomes grown in Jamaica. Mod. Chem. Appl., 2014, 2(140), 2-9.
[18]
Tang, J.; Ji, H.; Ren, J.; Li, M.; Zheng, N.; Wu, L. Solid lipid nanoparticles with TPGS and Brij 78: A co-delivery vehicle of curcumin and piperine for reversing P-glycoprotein-mediated multidrug resistance in vitro. Oncol. Lett., 2017, 13(1), 389-395.
[19]
Baek, J.S.; Cho, C.W. A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells. Oncotarget, 2017, 8(18), 30369.
[20]
Zhao, M.; Zhao, M.; Fu, C.; Yu, Y.; Fu, A. Targeted therapy of intracranial glioma model mice with curcumin nanoliposomes. Int. J. Nanomedi, 2018, 13, 1601.
[21]
Ravichandiran, V.; Masilamani, K.; Senthilnathan, B.; Maheshwaran, A.; Wui Wong, T.; Roy, P. Quercetin-decorated curcumin liposome design for cancer therapy: In-vitro and in-vivo studies. Curr. Drug Deliv., 2017, 14(8), 1053-1059.
[22]
Tefas, L.R.; Sylvester, B.; Tomuta, I.; Sesarman, A.; Licarete, E.; Banciu, M.; Porfire, A. Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach. Drug Des. Develop Ther., 2017, 11, 1605-16021.
[23]
Hong, J.; Liu, Y.; Xiao, Y.; Yang, X.; Su, W.; Zhang, M.; Liao, Y.; Kuang, H.; Wang, X. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: In vitro and in vivo evaluation. Drug Deliv., 2017, 24(1), 109-120.
[24]
Sahu, B.P.; Hazarika, H.; Bharadwaj, R.; Loying, P.; Baishya, R.; Dash, S.; Das, M.K. Curcumin-docetaxel co-loaded nanosuspension for enhanced anti-breast cancer activity. Expert Opin. Drug Deliv., 2016, 13(8), 1065-1074.
[25]
Seleci, D.A.; Seleci, M.; Stahl, F.; Scheper, T. Tumor homing and penetrating peptide-conjugated niosomes as multi-drug carriers for tumor-targeted drug delivery. RSC Advan, 2017, 7(53), 33378-33384.
[26]
Szczepanowicz, K.; Jantas, D.; Piotrowski, M.; Staroń, J.; Leśkiewicz, M.; Regulska, M.; Lasoń, W.; Warszyński, P. Encapsulation of curcumin in polyelectrolyte nanocapsules and their neuroprotective activity. Nanotechnology, 2016, 27(35)355101
[27]
Kamaraj, S.; Palanisamy, U.M.; Mohamed, M.S.B.K.; Gangasalam, A.; Maria, G.A.; Kandasamy, R. Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier. Eur. J. Pharmaceut Sci., 2018, 116, 48-60.
[28]
de Matos, R.P.A.; Calmon, M.F.; Amantino, C.F.; Villa, L.L.; Primo, F.L.; Tedesco, A.C.; Rahal, P. Effect of curcumin-nanoemulsion associated with photodynamic therapy in cervical carcinoma cell lines. BioMed Res. Int.,2018, 2018.
[29]
Fan, R.; Li, X.; Deng, J.; Gao, X.; Zhou, L.; Zheng, Y.; Tong, A.; Zhang, X.; You, C.; Guo, G. Dual drug loaded biodegradable nanofibrous microsphere for improving anti-colon cancer activity. Sci. Reports,, 2016, 6, 28373.
[30]
Zhang, J.; Li, S.; An, F.F.; Liu, J.; Jin, S.; Zhang, J.C.; Wang, P.C.; Zhang, X.; Lee, C.S.; Liang, X.J. Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release. Nanoscale, 2015, 7(32), 13503-13510.
[31]
Luong, D.; Kesharwani, P.; Alsaab, H.O.; Sau, S.; Padhye, S.; Sarkar, F.H.; Iyer, A.K.2017 Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers. Colloids Surfaces B Biointerfaces, 2017, 157, 490-502.
[32]
Salehiabar, M.; Nosrati, H.; Javani, E.; Aliakbarzadeh, F.; Manjili, H.K.; Davaran, S.; Danafar, H. Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery. Int. J. Biol. Macromol., 2018, 115, 83-89.
[33]
Lu, M.; Chen, X.; Xiao, J.; Xiang, J.; Yang, L.; Chen, D. FOXO3a reverses the Cisplatin resistance in ovarian cancer. Arch. Med. Res., 2018, 49(2), 84-88.
[34]
Xu, Y.; Chen, W.R.; Tsosie, J.K.; Xie, X.; Li, P.; Wan, J.; He, C.; Chen, M. Niosomes encapsulation of curcumin: Characterisation and cytotoxic effect on ovarian cancer cells. J. Nanomater., 2016, 20166365295
[35]
Bondì, M.L.; Emma, M.R.; Botto, C.; Augello, G.; Azzolina, A.; Di Gaudio, F.; Craparo, E.F.; Cavallaro, G.; Bachvarov, D.; Cervello, M. Biocompatible lipid nanoparticles as carriers to improve curcumin efficacy in ovarian cancer treatment. J. Agricult Food Chem., 2017, 65(7), 1342-1352.
[36]
Baghbani, F.; Moztarzadeh, F. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets. Colloids Surfaces B Biointerfaces, 2017, 153, 132-140.
[37]
Luong, D.; Sau, S.; Kesharwani, P.; Iyer, A.K. Polyvalent folate-dendrimer-coated iron oxide theranostic nanoparticles for simultaneous magnetic resonance imaging and precise cancer cell targeting. Biomacromolecules, 2017, 18(4), 1197-1209.
[38]
Gawde, K.A.; Sau, S.; Tatiparti, K.; Kashaw, S.K.; Mehrmohammadi, M.; Azmi, A.S.; Iyer, A.K. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers. Colloids Surfaces B Biointerfaces, 2018, 167, 8-19.
[39]
McFaline-Figueroa, J.R.; Lee, E.Q. Brain tumors. Am. J. Med., 2018, 131(8), 874-882.
[40]
Maiti, P.; Al-Gharaibeh, A.; Kolli, N.; Dunbar, G.L. Solid lipid curcumin particles induce more DNA fragmentation and cell death in cultured human glioblastoma cells than does natural curcumin. Oxid. Med. Cell. Longev., 2017, 20179656719
[41]
Montalbán, M.G.; Coburn, J.M.; Lozano-Pérez, A.A.; Cenis, J.L.; Víllora, G.; Kaplan, D.L. Production of curcumin-loaded silk fibroin nanoparticles for cancer therapy. Nanomaterials, 2018, 8(2), 126.
[42]
Zhang, H.; Zhu, Y.; Sun, X.; He, X.; Wang, M.; Wang, Z.; Wang, Q.; Zhu, R.; Wang, S. Curcumin-loaded layered double hydroxide nanoparticles-induced autophagy for reducing glioma cell migration and invasion. J. Biomed. Nanotechnol., 2016, 12(11), 2051-2062.
[43]
Ghorbani, M.; Bigdeli, B.; Jalili-baleh, L.; Baharifar, H.; Akrami, M.; Dehghani, S.; Goliaei, B.; Amani, A.; Lotfabadi, A.; Rashedi, H.; Haririan, I. Curcumin-lipoic acid conjugate as a promising anticancer agent on the surface of gold-iron oxide nanocomposites: A pH-sensitive targeted drug delivery system for brain cancer theranostics. Eur. J.Pharmaceut Sci., 2018, 114, 175-188.
[44]
Custodio-Santos, T.; Videira, M.; Brito, M.A. Brain metastasization of breast cancer. Biochim. Biophys. Acta (BBA). Rev. Cancer, 2017, 1868(1), 132-147.
[45]
Engel, C.L.; Sharima Rasanayagam, M.; Gray, J.M.; Rizzo, J. Work and female breast cancer: The state of the evidence, 2002–2017. New Solutions, 2018, 28(1), 55-78.
[46]
Baek, J.S.; Cho, C.W. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake. Eur. J. Pharmaceut Biopharmaceut., 2017, 117, 132-140.
[47]
Khan, M.N.; Haggag, Y.A.; Lane, M.E.; McCarron, P.A.; Tambuwala, M.M. Polymeric nano-encapsulation of curcumin enhances its anti-cancer activity in breast (MDA-MB231) and lung (A549) cancer cells through reduction in expression of HIF-1α and nuclear p65 (Rel A). Curr. Drug Deliv., 2018, 15(2), 286-295.
[48]
Medel, S.; Syrova, Z.; Kovacik, L.; Hrdy, J.; Hornacek, M.; Jager, E.; Hruby, M.; Lund, R.; Cmarko, D.; Stepanek, P.; Raska, I. Curcumin-bortezomib loaded polymeric nanoparticles for synergistic cancer therapy. Eur. Polymer J., 2017, 93, 116-131.
[49]
Zhou, S.; Li, J.; Xu, H.; Zhang, S.; Chen, X.; Chen, W.; Yang, S.; Zhong, S.; Zhao, J.; Tang, J. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression. Gene, 2017, 622, 1-12.
[50]
Shukla, M.; Jaiswal, S.; Sharma, A.; Srivastava, P.K.; Arya, A.; Dwivedi, A.K.; Lal, J. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. Drug Develop. Industrial Pharm, 2017, 43(5), 847-861.
[51]
Malekmohammadi, S.; Hadadzadeh, H.; Farrokhpour, H.; Amirghofran, Z. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: A new nanoplatform for curcumin pH-controlled and targeted delivery. Soft Matter, 2018, 14(12), 2400-2410.
[52]
Bai, F.; Diao, J.; Wang, Y.; Sun, S.; Zhang, H.; Liu, Y.; Wang, Y.; Cao, J. A new water-soluble nanomicelle formed through self-assembly of pectin–curcumin conjugates: Preparation, characterization, and anticancer activity evaluation. J. . Agricult Food Chem., 2017, 65(32), 6840-6847.
[53]
Choi, J.S. Development of surface curcumin nanoparticles modified with biological macromolecules for anti-tumor effects. Int. J. Biol. Macromol., 2016, 92, 850-859.
[54]
Bugos, K.G. Issues in adult blood cancer survivorship care. Semin. Oncol. Nursing, 2015, 31(1), 60-66.
[55]
Guorgui, J.; Wang, R.; Mattheolabakis, G.; Mackenzie, G.G. Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin’s lymphoma in mice. Arch. Biochem. Biophys., 2018, 648, 12-19.
[56]
Petrov, P.D.; Yoncheva, K.; Gancheva, V.; Konstantinov, S.; Trzebicka, B. Multifunctional block copolymer nanocarriers for co-delivery of silver nanoparticles and curcumin: Synthesis and enhanced efficacy against tumor cells. Eur. Polymer J., 2016, 81, 24-33.
[57]
Dash, T.K.; Konkimalla, V.B. Selection of P-glycoprotein inhibitor and formulation of combinational nanoformulation containing selected agent curcumin and DOX for reversal of resistance in K562 cells. Pharmaceut. Res., 2017, 34(8), 1741-1750.
[58]
Tian, S.; Chen, H.; Tan, W. Targeting mitochondrial respiration as a therapeutic strategy for cervical cancer. Biochem. Biophys. Res. Commun., 2018, 499(4), 1019-1024.
[59]
Li, C.; Ge, X.; Wang, L. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer. Biomed. Pharmacother., 2017, 86, 628-636.
[60]
Khan, M.A.; Zafaryab, M.; Mehdi, S.H.; Ahmad, I.; Rizvi, M.; Moshahid, A. Physicochemical characterization of curcumin loaded chitosan nanoparticles: Implications in cervical cancer. Anticancer. Agents Med. Chem., 2018, 18(8), 1131-1137.
[61]
Wu, C. Systemic therapy for colon cancer. Surg. Oncol. Clin., 2018, 27(2), 235-242.
[62]
Jyoti, K.; Bhatia, R.K.; Martis, E.A.; Coutinho, E.C.; Jain, U.K.; Chandra, R.; Madan, J. Soluble curcumin amalgamated chitosan microspheres augmented drug delivery and cytotoxicity in colon cancer cells: In vitro and in vivo study. Colloids Surfaces B Biointerfaces, 2016, 148, 674-683.
[63]
Bagheri, R.; Sanaat, Z.; Zarghami, N. Synergistic effect of free and nano-encapsulated chrysin-curcumin on inhibition of hTERT gene expression in SW480 colorectal cancer cell line. Drug Res,, 2018, 68(06), 335-343.
[64]
Lotfi-Attari, J.; Pilehvar-Soltanahmadi, Y.; Dadashpour, M.; Alipour, S.; Farajzadeh, R.; Javidfar, S.; Zarghami, N. Co-delivery of curcumin and chrysin by polymeric nanoparticles inhibit synergistically growth and hTERT gene expression in human colorectal cancer cells. Nutrition Cancer, 2017, 69(8), 1290-1299.
[65]
Sesarman, A.; Tefas, L.; Sylvester, B.; Licarete, E.; Rauca, V.; Luput, L.; Patras, L.; Banciu, M.; Porfire, A. Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells. Pharmacol. Reports,, 2018, 70(2), 331-339.
[66]
Varshosaz, J.; Jajanian-Najafabadi, A.; Soleymani, A.; Khajavinia, A. Poly (butylene adipate-co-terephthalate) electrospun nanofibers loaded with 5-fluorouracil and curcumin in treatment of colorectal cancer cells. Polymer Testing, 2018, 65, 217-230.
[67]
Kumar, S.U.; Kumar, V.; Priyadarshi, R.; Gopinath, P.; Negi, Y.S. pH-responsive prodrug nanoparticles based on xylan-curcumin conjugate for the efficient delivery of curcumin in cancer therapy. Carbohydr. Polymers,, 2018, 188, 252-259.
[68]
Sabra, R.; Billa, N.; Roberts, C.J. An augmented delivery of the anticancer agent, curcumin, to the colon. React. Funct. Polymers,, 2018, 123, 54-60.
[69]
Kumari, M.; Ray, L.; Purohit, M.P.; Patnaik, S.; Pant, A.B.; Shukla, Y.; Kumar, P.; Gupta, K.C. Curcumin loading potentiates the chemotherapeutic efficacy of selenium nanoparticles in HCT116 cells and Ehrlich’s ascites carcinoma bearing mice. Eur. J. Pharmaceut. Biopharmaceut, 2017, 117, 346-362.
[70]
Xu, H.; Wang, T.; Yang, C.; Li, X.; Liu, G.; Yang, Z.; Singh, P.K.; Krishnan, S.; Ding, D. Supramolecular nanofibers of curcumin for highly amplified radiosensitization of colorectal cancers to ionizing radiation. Adv. Funct. Mater., 2018, 28(14)1707140
[71]
Canal, C.; Fontelo, R.; Hamouda, I.; Guillem-Marti, J.; Cvelbar, U.; Ginebra, M.P. Plasma-induced selectivity in bone cancer cells death. Free Radic. Biol. Med., 2017, 110, 72-80.
[72]
Wang, L.; Wang, W.; Rui, Z.; Zhou, D. The effective combination therapy against human osteosarcoma: Doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system. Drug Deliv., 2016, 23(9), 3200-3208.
[73]
Otsubo, K.; Okamoto, I.; Hamada, N.; Nakanishi, Y. Anticancer drug treatment for advanced lung cancer with interstitial lung disease. Respir. Invest., 2018, 56(4), 307-311.
[74]
Sadeghzadeh, H.; Pilehvar-Soltanahmadi, Y.; Akbarzadeh, A.; Dariushnejad, H.; Sanjarian, F.; Zarghami, N. The effects of nanoencapsulated curcumin-Fe3O4 on proliferation and hTERT gene expression in lung cancer cells. Anticancer. Agents Med. Chem., 2017, 17(10), 1363-1373.
[75]
Ranjan, A.P.; Mukerjee, A.; Gdowski, A.; Helson, L.; Bouchard, A.; Majeed, M.; Vishwanatha, J.K. Curcumin-ER prolonged subcutaneous delivery for the treatment of non-small cell lung cancer. J. Biomed. Nanotechnol., 2016, 12(4), 679-688.
[76]
Huang, W.T.; Larsson, M.; Lee, Y.C.; Liu, D.M.; Chiou, G.Y. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells. Eur. J. Pharmaceut. Biopharmaceut, 2016, 109, 165-173.
[77]
Jyoti, K.; Pandey, R.S.; Kush, P.; Kaushik, D.; Jain, U.K.; Madan, J. Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells. Int. J. Biol. Macromol., 2017, 98, 50-58.
[78]
Allum, W.; Lordick, F.; Alsina, M.; Andritsch, E.; Ba-Ssalamah, A.; Beishon, M.; Braga, M.; Caballero, C.; Carneiro, F.; Cassinello, F.; Dekker, J.W. ECCO essential requirements for quality cancer care: oesophageal and gastric cancer. Crit. Rev. Oncol. Hematol., 2018, 122, 179-193.
[79]
Dhivya, R.; Ranjani, J.; Bowen, P.K.; Rajendhran, J.; Mayandi, J.; Annaraj, J. Biocompatible curcumin loaded PMMA-PEG/ZnO nanocomposite induce apoptosis and cytotoxicity in human gastric cancer cells. Mater. Sci.Engin C, 2017, 80, 59-68.
[80]
Jiang, H.; Geng, D.; Liu, H.; Li, Z.; Cao, J. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors. Drug Deliv., 2016, 23(9), 3665-3673.
[81]
Xu, J.W.; Wang, L.; Cheng, Y.G.; Zhang, G.Y.; Hu, S.Y.; Zhou, B.; Zhan, H.X. Immunotherapy for pancreatic cancer: A long and hopeful journey. Cancer Lett., 2018, 425, 143-151.
[82]
Arya, G.; Das, M.; Sahoo, S.K. Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer. Biomed. Pharmacother., 2018, 102, 555-566.
[83]
Le, U.M.; Hartman, A.; Pillai, G. Enhanced selective cellular uptake and cytotoxicity of epidermal growth factor-conjugated liposomes containing curcumin on EGFR-overexpressed pancreatic cancer cells. J. Drug Target., 2018, 26(8), 676-683.
[84]
Bisht, S.; Schlesinger, M.; Rupp, A.; Schubert, R.; Nolting, J.; Wenzel, J.; Holdenrieder, S.; Brossart, P.; Bendas, G.; Feldmann, G. A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies. J. Nanobiotechnol, 2016, 14(1), 57.
[85]
Anajafi, T.; Yu, J.; Sedigh, A.; Haldar, M.K.; Muhonen, W.W.; Oberlander, S.; Wasness, H.; Froberg, J.; Molla, M.S.; Katti, K.S.; Choi, Y. Nuclear localizing peptide-conjugated, redox-sensitive polymersomes for delivering curcumin and doxorubicin to pancreatic cancer microtumors. Mol. Pharmaceut, 2017, 14(6), 1916-1928.
[86]
Song, P.; Hai, Y.; Ma, W.; Zhao, L.; Wang, X.; Xie, Q.; Li, Y.; Wu, Z.; Li, Y.; Li, H. Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis. Medicine , 2018, 97(18)e0613
[87]
Cao, Y.; Yi, J.; Yang, X.; Liu, L.; Yu, C.; Huang, Y.; Sun, L.; Bao, Y.; Li, Y. Efficient cancer regression by a thermosensitive liposome for photoacoustic imaging-guided photothermal/chemo combinatorial therapy. Biomacromolecules, 2017, 18(8), 2306-2314.
[88]
Coughlin, S.S.; Williams, L.B.; Besenyi, G.M.; Jackson, L.W.; Anglin, J. Advancing uterine cancer survivorship among african american women. J. Natl. Med. Assoc., 2018, 110(4), 391-395.
[89]
Kumar, A.; Sirohi, V.K.; Anum, F.; Singh, P.K.; Gupta, K.; Gupta, D.; Saraf, S.A.; Dwivedi, A.; Chourasia, M.K. Enhanced apoptosis, survivin down-regulation and assisted immunochemotherapy by curcumin loaded amphiphilic mixed micelles for subjugating endometrial cancer. Nanomed. Nanotechnol. Biol. Med., 2017, 13(6), 1953-1963.
[90]
Simões, M.C.F.; Sousa, J.J.S.; Pais, A.A.C.C. Skin cancer and new treatment perspectives: A review. Cancer Lett., 2015, 357(1), 8-42.
[91]
Mangalathillam, S.; Rejinold, N.S.; Nair, A.; Lakshmanan, V.K.; Nair, S.V.; Jayakumar, R. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale, 2012, 4(1), 239-250.
[92]
Araujo, C.A.C.; Leon, L.L. Biological activities of Curcuma longa L. Mem.órias do Instituto Oswaldo Cruz, 2001, 96(5), 723-728.
[93]
Pae, H.O.; Jeong, S.O.; Jeong, G.S.; Kim, K.M.; Kim, H.S.; Kim, S.A.; Kim, Y.C.; Kang, S.D.; Kim, B.N.; Chung, H.T. Curcumin induces pro-apoptotic endoplasmic reticulum stress in human leukemia HL-60 cells. Biochem. Biophys. Res. Commun., 2007, 353(4), 1040-1045.
[94]
Chopra, D.; Ray, L.; Dwivedi, A.; Tiwari, S.K.; Singh, J.; Singh, K.P.; Kushwaha, H.N.; Jahan, S.; Pandey, A.; Gupta, S.K.; Chaturvedi, R.K. Photoprotective efficiency of PLGA-curcumin nanoparticles versus curcumin through the involvement of ERK/AKT pathway under ambient UV-R exposure in HaCaT cell line. Biomaterials, 2016, 84, 25-41.